AI Analysis AI Analysis of NPCE
AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment
Trading Strategy
PDF

NeuroPace, Inc. stock upgraded from Hold/Accumulate to Buy Candidate after Monday trading session
(Updated on Nov 17, 2025)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Nov 06, 2025 Gain 1.33%

The NeuroPace, Inc. stock price gained 0.0773% on the last trading day (Monday, 17th Nov 2025), rising from $12.94 to $12.95. During the last trading day the stock fluctuated 3.40% from a day low at $12.65 to a day high of $13.08. The price has risen in 7 of the last 10 days and is up by 37.77% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 67 thousand more shares were traded than the day before. In total, 206 thousand shares were bought and sold for approximately $2.67 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $13.67 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 34.97% during the next 3 months and, with a 90% probability hold a price between $13.36 and $18.44 at the end of this 3-month period.

NPCE Signals & Forecast

The NeuroPace, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $13.18. On a fall, the stock will find some support from the long-term average at approximately $11.15. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, November 12, 2025, and so far it has fallen -4.07%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for NeuroPace, Inc. stock

NeuroPace, Inc. finds support from accumulated volume at $12.78 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.430 between high and low, or 3.40%. For the last week, the stock has had daily average volatility of 4.09%.

Our recommended stop-loss: $12.30 (-5.05%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (NPCE) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect NeuroPace, Inc. to open at $12.89, and during the day (based on 14 day Average True Range), to move between $12.61 and $13.29, which gives a possible trading interval of +/-$0.678 (+/-5.38%) up or down from last closing price. If NeuroPace, Inc. takes out the full calculated possible swing range there will be an estimated 5.38% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $12.98 (0.23%) than the support at $12.78 (1.31%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is NeuroPace, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for NeuroPace, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

Current score: 1.680 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $12.89 ( 0.438%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk

NPCE Performance

Trading levels for NPCE

Full Access. No Commitment. 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 5 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 13.32 2.88%
R2 13.16 1.61%
R1 13.06 0.83%
Price 12.95
S1 12.73 -1.71%
S2 12.63 -2.49%
S3 12.46 -3.76%

Accumulated Volume Support & Resistance Levels

Level Price
R3 13.45 3.86%
R2 13.12 1.31%
R1 12.98 0.232%
Price 12.95
S1 12.78 -1.31%
S2 10.01 -22.70%
S3 9.94 -23.24%

FAQ

What is the symbol for NeuroPace, Inc. Stock and on which exchange is it traded?
The symbol for NeuroPace, Inc. is NPCE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NeuroPace, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for NeuroPace, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.

How to buy NeuroPace, Inc. Stock?
NeuroPace, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NeuroPace, Inc. Stock.

What's the current price of NeuroPace, Inc. Stock?
As of the end of day on the Nov 17, 2025, the price of an NeuroPace, Inc. (NPCE) share was $12.95.

What is the 52-week high and low for NeuroPace, Inc. Stock?
The 52-week high for NeuroPace, Inc. Stock is $18.97 and the 52-week low is $7.56.

What is the market capitalization of NeuroPace, Inc. Stock?
As of the Nov 17, 2025, the market capitalization of NeuroPace, Inc. is 431.288M.

When is the next earnings date for NeuroPace, Inc.?
The upcoming earnings date for NeuroPace, Inc. is Mar 03, 2026.
Click to get the best stock tips daily for free!
ABOUT NEUROPACE, INC.
NeuroPace
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilitie...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE